// App-Quantinova.ai

11045 : mRNA expression profiles in circulating tumor cells (CTCs) of patients with metastatic breast cancer (MBC) treated with aromatase inhibitors (AI).

Researchers

Presenter

  • Esther Anneke Reijm

Principal Investigators

  • Joan Bolt-de Vries

  • Anne M. van Galen

  • Jaco Kraan

  • Maurice P. H. M. Jansen

  • Jan-Willem Gratama

  • John A. Foekens

  • John W. M. Martens

  • Els M. J. J. Berns

  • Stefan Sleijfer

  • Bianca Mostert

  • Wendy Onstenk

  • Dieter Peeters

  • Luc Yves Dirix

  • Caroline Seynaeve

  • A. Jager

  • Felix E. de Jongh

  • Paul Hamberg

Medical Centers

  • TCRG-A/Oncology Centre, St. Augustinus Hospital, Antwerp, Belgium

  • Translational Cancer Research Unit, University of Antwerp and GZA Hospitals Sint-Augustinus, Antwerp, Belgium

  • Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands

  • Department of Internal Medicine, Ikazia Hospital, Rotterdam, Netherlands

  • Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands

  • Erasmus MC Cancer Institute, Department of Medical Oncology and Cancer Genomics Netherlands, Rotterdam, Netherlands

Locations

  • Belgium

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Anastrozole

  • Exemestane

  • Letrozole

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved